Kenichi Nakamura

13PUBLICATIONS
103CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsOncology and carcinogenesis not elsewhere classifiedGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 29, 2026
Integrating DNA Mutations and RNA Expression of Cancer Driver Genes in Asian Rare Cancers: A Pan-Cancer Analysis.

|Jun 26, 2026
Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer.

|Feb 04, 2026
Real-world characterization of patients with advanced or metastatic liposarcoma, including dedifferentiated liposarcoma, in Japan in the MASTER KEY project.

Hitomi Sumiyoshi Okuma, Kenji Tsuchihashi, Eishi Baba

|Oct 06, 2025
Emergence of PALB2 Reversion Mutations as a Mechanism of Resistance to Niraparib in Breast Cancer: A Case Report.

Maako Kawamura, Hiroshi Tada, Hidekazu Shirota

|Sep 17, 2025
FGFR2 Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan-Asian Study.

Yuta Maruki, Yasushi Yatabe, Chiharu Mizoguchi

|Aug 26, 2024
Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018).

Atsuo Takashima, Tetsuya Hamaguchi, Junki Mizusawa

Pageof 3

Frequent Collaborators

5 joint publications

Kan Yonemori

4 joint publications

Hitomi Sumiyoshi Okuma

3 joint publications

Akihiro Hirakawa

3 joint publications

Ryo Sadachi